申请人:Ahlin Kristofer
公开号:US20110118275A1
公开(公告)日:2011-05-19
The present invention relates to a compound of formula (I)
wherein
R
1
is hydrogen or methyl, or a pharmaceutically acceptable salt thereof, pharmaceutical formulations containing said compound, to the use of said active compound in therapy, as well as intermediates.
本发明涉及一种化合物的公式(I),其中R1为氢或甲基,或其药用盐,含有该化合物的药物配方,以及在治疗中使用该活性化合物,以及中间体。